• In late June 2026, SharonAI Holdings Inc. (NasdaqCM: SHAZ) was added to multiple Russell indices and closed an oversubscribed US$1.60 billion private placement to help fund a six-year compute collaboration with NVIDIA, including plans for an AI factory in Australia using up to 40,000 Grace Blackwell GB300 GPUs.
• The combination of broad Russell index inclusion and backing from institutional investors such as Situational Awareness L.P. and Oaktree Capital Management L.P. signals growing benchmark representation and institutional attention around SharonAI’s large-scale infrastructure build-out.
• We’ll now examine how this oversubscribed US$1.60 billion financing and NVIDIA collaboration could shape SharonAI Holdings’ evolving investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

What Is SharonAI Holdings' Investment Narrative?

For SharonAI, the core belief is that its aggressive AI infrastructure build-out can eventually justify significant current losses and a volatile share price. The oversubscribed US$1.60 billion private placement and expanded NVIDIA collaboration materially sharpen that story, shifting near-term catalysts toward execution of the Australian AI factory, delivery against the large ESDS and global tech customer contracts, and how efficiently new capacity is filled. At the same time, they amplify key risks: heavier balance sheet commitments, reliance on a still-new leadership and board to manage very large projects, and the possibility that rapid capacity expansion outpaces sustainable demand or returns. The recent surge in index inclusions and financing helps visibility and funding, but it also raises the bar on SharonAI’s operational delivery and capital discipline.

However, investors should be aware of how much execution risk now sits around this rapid scale-up. Our comprehensive valuation report raises the possibility that SharonAI Holdings is priced higher than what may be justified by its financials.

Exploring Other Perspectives

Simply Wall St Community members currently provide 1 fair value estimate for SharonAI, clustering tightly around US$105.33 per share. That single-point view sits against a business where the fresh US$1.60 billion funding and NVIDIA-backed expansion have increased both the potential upside from successful deployment and the operational and financing risks if timelines or utilization rates disappoint, so it is worth weighing several different viewpoints before forming a view.

Explore another fair value estimate on SharonAI Holdings - why the stock might be worth as much as 32% more than the current price!

Decide For Yourself

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your SharonAI Holdings research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free SharonAI Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate SharonAI Holdings' overall financial health at a glance.

Searching For A Fresh Perspective?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.